These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28665229)

  • 1. The Importance of Epitope Density in Selecting a Sensitive Positive IHC Control.
    Vani K; Sompuram SR; Schaedle AK; Balasubramanian A; Pilichowska M; Naber S; Goldsmith JD; Chang KG; Noubary F; Bogen SA
    J Histochem Cytochem; 2017 Aug; 65(8):463-477. PubMed ID: 28665229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytic Response Curves of Clinical Breast Cancer IHC Tests.
    Vani K; Sompuram SR; Schaedle AK; Balasubramanian A; Bogen SA
    J Histochem Cytochem; 2017 May; 65(5):273-283. PubMed ID: 28438091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting an Optimal Positive IHC Control for Verifying Antigen Retrieval.
    Sompuram SR; Vani K; Schaedle AK; Balasubramanian A; Bogen SA
    J Histochem Cytochem; 2019 Apr; 67(4):275-289. PubMed ID: 30628843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Assessment of Immunohistochemistry Laboratory Performance by Measuring Analytic Response Curves and Limits of Detection.
    Sompuram SR; Vani K; Schaedle AK; Balasubramanian A; Bogen SA
    Arch Pathol Lab Med; 2018 Jul; 142(7):851-862. PubMed ID: 29595317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardizing Immunohistochemistry: A New Reference Control for Detecting Staining Problems.
    Sompuram SR; Vani K; Tracey B; Kamstock DA; Bogen SA
    J Histochem Cytochem; 2015 Sep; 63(9):681-90. PubMed ID: 25940339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Linear Range HER2/Estrogen Receptor/Progesterone Receptor IHControls for Daily Quality Assurance.
    Sompuram SR; Vani K; Ryan L; Johnson C; Szabolcs M; Peruyero L; Balaton A; Pierrot S; Joseph L; Pilichowska M; Naber S; Goldsmith J; Green S; Bogen SA
    Am J Clin Pathol; 2023 Mar; 159(3):274-282. PubMed ID: 36779320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental validation of peptide immunohistochemistry controls.
    Bogen SA; Vani K; McGraw B; Federico V; Habib I; Zeheb R; Luther E; Tristram C; Sompuram SR
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):239-46. PubMed ID: 19077907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapy.
    Phillips T; Murray G; Wakamiya K; Askaa J; Huang D; Welcher R; Pii K; Allred DC
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):325-31. PubMed ID: 17721279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative immunohistochemistry using the CAS 200/486 image analysis system in invasive breast carcinoma: a reproducibility study.
    Makkink-Nombrado SV; Baak JP; Schuurmans L; Theeuwes JW; van der Aa T
    Anal Cell Pathol; 1995 Apr; 8(3):227-45. PubMed ID: 7547496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
    Neven P; Van Calster B; Van den Bempt I; Van Huffel S; Van Belle V; Hendrickx W; Decock J; Wildiers H; Paridaens R; Amant F; Leunen K; Berteloot P; Timmerman D; Van Limbergen E; Weltens C; Van den Bogaert W; Smeets A; Vergote I; Christiaens MR; Drijkoningen M
    Breast Cancer Res Treat; 2008 Jul; 110(1):153-9. PubMed ID: 17687649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
    Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT
    Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates.
    Marinšek ZP; Nolde N; Kardum-Skelin I; Nizzoli R; Onal B; Rezanko T; Tani E; Ostović KT; Vielh P; Schmitt F; Kocjan G
    Cytopathology; 2013 Feb; 24(1):7-20. PubMed ID: 23082931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of polysomy-17 on HER2 status and the correlations of HER2 status with prognostic variables (ER, PR, p53, Ki-67) in epithelial ovarian cancer: a tissue microarray study using immunohistochemistry and fluorescent in situ hybridization.
    Lin CK; Lin WL; Chen FL; Lee MY; Kuo JF; Ruan A; Tyan YS; Chiang H; Chou MC; Han CP
    Int J Gynecol Pathol; 2011 Jul; 30(4):372-9. PubMed ID: 21623202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast.
    Lin Y; Hatem J; Wang J; Quinn A; Hicks D; Tang P
    Biotech Histochem; 2011 Oct; 86(5):345-50. PubMed ID: 20701550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations.
    Hanley KZ; Birdsong GG; Cohen C; Siddiqui MT
    Cancer; 2009 Aug; 117(4):279-88. PubMed ID: 19551847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.
    Wesseling J; Tinterri C; Sapino A; Zanconati F; Lutke-Holzik M; Nguyen B; Deck KB; Querzoli P; Perin T; Giardina C; Seitz G; Guinebretière JM; Barone J; Dekker L; de Snoo F; Stork-Sloots L; Roepman P; Watanabe T; Cusumano P
    Virchows Arch; 2016 Sep; 469(3):297-304. PubMed ID: 27377889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma.
    Fisher ER; Anderson S; Dean S; Dabbs D; Fisher B; Siderits R; Pritchard J; Pereira T; Geyer C; Wolmark N
    Cancer; 2005 Jan; 103(1):164-73. PubMed ID: 15565575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
    Mann GB; Fahey VD; Feleppa F; Buchanan MR
    J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levey-Jennings Analysis Uncovers Unsuspected Causes of Immunohistochemistry Stain Variability.
    Vani K; Sompuram SR; Naber SP; Goldsmith JD; Fulton R; Bogen SA
    Appl Immunohistochem Mol Morphol; 2016; 24(10):688-694. PubMed ID: 26469328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of receptors for oestrogen and progesterone in endometrial glands and stroma during the oestrous cycle in Nelore (Bos taurus indicus) cows.
    Martin I; Torres Neto R; Oba E; Buratini J; Binelli M; Laufer-Amorim R; Ferreira JC
    Reprod Domest Anim; 2008 Aug; 43(4):415-21. PubMed ID: 18179635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.